Elamin Nadra E, Al-Ayadhi Laila Y
Autism Research & Treatment Center, Shaik AL-Amodi Autism Research Chair, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
Biomark Med. 2014;8(3):345-52. doi: 10.2217/bmm.14.1.
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by impairments in reciprocal social interactions as well as restricted, repetitive and stereotyped patterns of behavior. The etiology of ASD is not well understood, although many factors have been associated with its pathogenesis, such genetic, neurological, environmental and immunological factors. Several studies have reported the production of numerous autoantibodies that react with specific brain proteins and brain tissues in autistic children and alter the function of the attacked brains tissue. In addition, the potential role of maternal autoantibodies to the fatal brain in the etiology of some cases of autism has also been reported. Identification and understanding of the role of brain autoantibodies as biological biomarkers may allow earlier detection of ASD, lead to a better understanding of the pathogenesis of ASD and have important therapeutic implications.
自闭症谱系障碍(ASD)是一种复杂的神经发育障碍,其特征是社交互动障碍以及行为模式受限、重复和刻板。尽管许多因素与ASD的发病机制有关,如遗传、神经、环境和免疫因素,但ASD的病因仍未完全明确。多项研究报告称,自闭症儿童体内产生了大量与特定脑蛋白和脑组织发生反应的自身抗体,这些抗体改变了被攻击脑组织的功能。此外,也有报道称母体自身抗体对胎儿大脑在某些自闭症病例病因中的潜在作用。识别并理解脑自身抗体作为生物标志物的作用,可能有助于更早地检测出自闭症谱系障碍,更好地理解其发病机制,并具有重要的治疗意义。